CURALEAF HOLDINGS INC

Curaleaf ramps up takeover push for Aurora Cannabis, filing against its ATM program to protect shareholder value and boost its bid’s appeal.

Explore Curaleaf Holdings’ leadership in the North American cannabis market—market cap, stock trends, and its integrated cultivation‑dispensary model.

Curaleaf’s Florida launch & Aurora bid reveal a bold growth strategy—boosting retail reach while navigating shareholder pushback.

Curaleaf Holdings Inc. announces a 1:3 reverse stock split on June 5 2026 to boost share price and liquidity for institutional investors while keeping market cap steady.

Curaleaf Holdings plans a U.S. exchange uplisting and a 1:3 reverse split to boost liquidity and meet exchange requirements, positioning the cannabis company for growth.

Curaleaf leads the largest medical‑cannabis patient survey, revealing real‑world benefits for anxiety, depression and PTSD—offering hope and evidence for mental‑health treatment.

Curaleaf Holdings joins the 38th ROTH Conference, showcasing leadership, stakeholder engagement and growth strategy in the cannabis market.

Curaleaf Holdings faces steep volatility and negative earnings amid a booming global cannabis market; discover why investors should watch its turnaround strategy closely.

Curaleaf’s bold restructuring—bundling a special meeting with its AGM—aims to keep its Canadian roots while gaining Delaware’s legal flexibility, a move that could reshape investor sentiment and the company’s future in a volatile cannabis market.

Curaleaf launches adult‑use sales in Maine, boosting market reach despite a negative P/E and volatile stock, showing investor optimism amid cannabis industry growth.